Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.

Mayr C, Hemann MT, Bartel DP.

Science. 2007 Mar 16;315(5818):1576-9. Epub 2007 Feb 22.

PMID:
17322030
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Lee YS, Dutta A.

Genes Dev. 2007 May 1;21(9):1025-30. Epub 2007 Apr 16.

PMID:
17437991
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development.

De Vito C, Riggi N, Suvà ML, Janiszewska M, Horlbeck J, Baumer K, Provero P, Stamenkovic I.

PLoS One. 2011;6(8):e23592. doi: 10.1371/journal.pone.0023592. Epub 2011 Aug 10.

PMID:
21853155
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.

Palmieri D, D'Angelo D, Valentino T, De Martino I, Ferraro A, Wierinckx A, Fedele M, Trouillas J, Fusco A.

Oncogene. 2012 Aug 23;31(34):3857-65. doi: 10.1038/onc.2011.557. Epub 2011 Dec 5.

PMID:
22139073
[PubMed - indexed for MEDLINE]
5.

Let-7 expression defines two differentiation stages of cancer.

Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME.

Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11400-5. Epub 2007 Jun 28.

PMID:
17600087
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.

Peng Y, Laser J, Shi G, Mittal K, Melamed J, Lee P, Wei JJ.

Mol Cancer Res. 2008 Apr;6(4):663-73. doi: 10.1158/1541-7786.MCR-07-0370.

PMID:
18403645
[PubMed - indexed for MEDLINE]
Free Article
7.

HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.

Wu J, Liu Z, Shao C, Gong Y, Hernando E, Lee P, Narita M, Muller W, Liu J, Wei JJ.

Cancer Res. 2011 Jan 15;71(2):349-59. doi: 10.1158/0008-5472.CAN-10-2550. Epub 2011 Jan 11.

PMID:
21224353
[PubMed - indexed for MEDLINE]
Free Article
8.

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.

Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C.

Br J Cancer. 2011 Jul 12;105(2):296-303. doi: 10.1038/bjc.2011.220. Epub 2011 Jun 7.

PMID:
21654684
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.

Jiang Y, Wu Y, Greenlee AR, Wu J, Han Z, Li X, Zhao Y.

Toxicol Sci. 2011 Jan;119(1):50-60. doi: 10.1093/toxsci/kfq306. Epub 2010 Oct 1.

PMID:
20889678
[PubMed - indexed for MEDLINE]
Free Article
10.

MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1).

Rice SJ, Lai SC, Wood LW, Helsley KR, Runkle EA, Winslow MM, Mu D.

J Biol Chem. 2013 Jun 7;288(23):16348-60. doi: 10.1074/jbc.M113.474643. Epub 2013 Apr 26.

PMID:
23625920
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

HMGA2 functions as a competing endogenous RNA to promote lung cancer progression.

Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J.

Nature. 2014 Jan 9;505(7482):212-7. doi: 10.1038/nature12785. Epub 2013 Dec 4.

PMID:
24305048
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Impaired microRNA processing enhances cellular transformation and tumorigenesis.

Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T.

Nat Genet. 2007 May;39(5):673-7. Epub 2007 Apr 1.

PMID:
17401365
[PubMed - indexed for MEDLINE]
13.

hF-LANa, a human homologue of Derlin family, regulating the expression of cancer-related genes promotes NIH3T3 cell transformation.

Hu Y, Ying H, Xu Y.

Cancer Lett. 2007 Dec 18;258(2):171-80. Epub 2007 Oct 30.

PMID:
17977649
[PubMed - indexed for MEDLINE]
14.

Oncogenic HMGA2: short or small?

Young AR, Narita M.

Genes Dev. 2007 May 1;21(9):1005-9. Review. No abstract available.

PMID:
17473167
[PubMed - indexed for MEDLINE]
Free Article
15.

Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.

Chen F, Chen C, Yang S, Gong W, Wang Y, Cianflone K, Tang J, Wang DW.

PLoS One. 2012;7(6):e39197. doi: 10.1371/journal.pone.0039197. Epub 2012 Jun 25.

PMID:
22761738
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.

Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ.

Mol Cancer. 2007 Jan 14;6:5.

PMID:
17222355
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Do cells let-7 determine stemness?

Dröge P, Davey CA.

Cell Stem Cell. 2008 Jan 10;2(1):8-9. doi: 10.1016/j.stem.2007.12.003.

PMID:
18371414
[PubMed - indexed for MEDLINE]
Free Article
18.

Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.

Manikandan M, Munirajan AK.

OMICS. 2014 Feb;18(2):142-54. doi: 10.1089/omi.2013.0098. Epub 2013 Nov 28.

PMID:
24286505
[PubMed - indexed for MEDLINE]
19.

HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.

Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y, Nakao M.

Am J Pathol. 2009 Mar;174(3):854-68. doi: 10.2353/ajpath.2009.080523. Epub 2009 Jan 29.

PMID:
19179606
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors.

Jiao LR, Frampton AE, Jacob J, Pellegrino L, Krell J, Giamas G, Tsim N, Vlavianos P, Cohen P, Ahmad R, Keller A, Habib NA, Stebbing J, Castellano L.

PLoS One. 2012;7(2):e32068. doi: 10.1371/journal.pone.0032068. Epub 2012 Feb 22.

PMID:
22384141
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk